Not yet investigated
What we have so far
COSMOS randomised 21,442 people for three and a half years: no effect on the primary endpoint, a 27% reduction in cardiovascular death on a secondary one.
This star is on the map because the show intends to take the question apart properly — the trials, how it is actually tested, whether the thing sold is the thing studied. That work is not done yet, and nothing here should be read as a conclusion. When the investigation is published it will appear on this page.